期刊文献+

神经酰胺在非酒精性脂肪性肝病发生发展中的作用 被引量:1

Role of ceramide in development and progression of nonalcoholic fatty liver disease
下载PDF
导出
摘要 非酒精性脂肪性肝病(NAFLD)是除外酒精和其他明确的肝损害因素所致的,以弥漫性肝细胞大泡性脂肪变为主要特征的临床病理综合征。"二次打击"学说可以部分解释NAFLD的发病机制。神经酰胺是NAFLD发生发展中关键的分子信使,而且其作为一种鞘脂与"二次打击学说"密切相关。对神经酰胺在NAFLD中的作用进行了综述。 Nonalcoholic fatty liver disease( NAFLD) is a clinicopathological syndrome caused by liver damage factors except alcohol and has the major feature of diffuse macrovesicular hepatocyte steatosis. The " two-hit " hypothesis can partly explain the pathogenesis of NAFLD. Recent studies have found that ceramide is a key molecular messenger involved in the development and progression of NAFLD,and as a sphingolipid,it is closely associated with the " two-hit" hypothesis. This article reviews the role of ceramide in NAFLD.
出处 《临床肝胆病杂志》 CAS 2017年第8期1584-1588,共5页 Journal of Clinical Hepatology
基金 基金项目:陕西省优势学科(陕教位[2014]3号文件)
关键词 脂肪肝 神经酰胺类 综述 fatty liver ceramides review
  • 相关文献

参考文献4

二级参考文献174

  • 1Yu-Tao Zhan,Wei An.Roles of liver innate immune cells in nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2010,16(37):4652-4660. 被引量:35
  • 2Liang Shuo Hu,Jacob George,Jian Hua Wang.Current concepts on the role of nitric oxide in portal hypertension[J].World Journal of Gastroenterology,2013,19(11):1707-1717. 被引量:18
  • 3Browning JD,Szczepaniak LS,Dobbins R,et al.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity[J].Hepatology,2004,40(6):1387-1395.
  • 4Bedogni G,Miglioli L,Masutti F,et al.Prevalence of and risk factors for nonalcoholic fatty liver disease:the Dionysos nutrition and liver study[J].Hepatology,2005,42(1):44-52.
  • 5Kirovski G,Schacherer D,Wobser H,et al.Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric,biochemical and sonographic characteristics[J].Int J Clin Exp Med,2010,3(3):202-210.
  • 6Maher JJ,Leon P,Ryan JC.Beyond insulin resistance:innate immunity in nonalcoholic steatohepatitis[J].Hepatology,2008,48(2):670-678.
  • 7Baffy G.Kupffer cells in non-alcoholic fatty liver disease:the emerging view[J].J Hepatol,2009,51 (1):212-223.
  • 8Dowman JK,Tomlinson JW,Newsome PN.Pathogenesis of non-alcoholic fatty liver disease[J].QJM,2009,103 (2):71-83.
  • 9Giovanni M, Maurizio C, Franco DM, et al. Nonalco- holic steatohepatitis versus steatosis: adipose tissue in- sulin resistance and dysfunctional response to fat in- gestion predict liver injury and altered glucose and lip- oprotein metabolism [ J ]. Hepatology, 2012,56 ( 3 ) : 933-942.
  • 10Musso G, Gambino R, Cassader M. Nonalcoholic fatty liver disease from pathogenesis to management: an up- date[J]. Obes Rev,2010,11 (6) :450-445.

共引文献53

同被引文献13

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部